In 2005, we teamed up with the Australian National University (ANU) to establish the ANU-MTAA Super Venture Capital Fund. Managed by ANU Connect Ventures, the fund supports startup and early-stage companies developing new and ground-breaking technologies. Here we look at how your super is helping build a brighter future for all.
EpiAxis Therapeutics revolutionising cancer research
EpiAxis Therapeutics is a Canberra based immuno-oncology company dedicated to the prevention of metastatic disease. The company’s primary aim is to prolong remission for solid tissue tumours.
While currently focused on the prevention of metastatic breast cancer, EpiAxis Therapeutics has plans to tackle other aggressive cancers in the future such as ovarian, pancreatic, colon, melanoma, lung and liver cancers.
The research and the intellectual property behind the program were developed by leading cancer researcher Professor Sudha Rao and her colleagues at the University of Canberra.
In late 2015, ANU Connect Ventures and MTAA Super led the seed investment round for EpiAxis Therapeutics, allowing them to launch a first-of-its-kind Phase 1b clinical trial using an ‘off label’ drug to treat cancer cells that cause metastasis to spread.
Results of the trial are expected in late 2019. The hope is that they will dramatically change the future of cancer treatment for the better.
After taking out the Startup Slam at the BIO-Europe Autumn 2016 event a major business partnering event for the global biotechnology industry EpiAxis Therapeutics is positioning itself to become the leading metastatic cancer prevention company.
Liquid Instruments redefining test and measurement instruments
Founded by Daniel Shaddock, a Professor in Physics at the ANU, the Liquid Instruments team is made up of experimental physicists and engineers with expertise in precision measurement and gravitational wave detector instrumentation.
The company spun out of the ANU after funding from ANU Connect Ventures and MTAA Super.
Liquid Instruments provides equipment to help scientists, engineers, students and professionals seamlessly acquire data, run measurements and control their experiments.
In 2018, Moku:Lab — Liquid Instruments’ first product was sold in more than 15 countries.
Moku:Lab combines twelve professional-grade test and measurement instruments into a single, software-configurable hardware platform. It incorporates a completely new type of computer chip that, unlike conventional CPUs, can perform millions of operations in a single clock cycle.
Moku:Lab is redefining test and measurement processes and providing greater mobility and flexibility in the lab, in the field, and on the production line.
Professor Shaddock says Moku:Lab was created because of a lack of innovation in the area over the last few decades.
“Anyone that designs, tests or works with electronic equipment of any sort will use test and measurement equipment. But if you walked into a lab from fifty years ago, the equipment would look the same as what we have today. What we’ve done is identify the steps in the test and measurement process from collecting data to presenting data — and, where possible, combined them into a single, portable device.”